Human mesenchymal stem cell-derived miR-3614-5p exosomes suppress progression of colorectal cancer by targeting IL7Rα.
Saved in:
| Title: | Human mesenchymal stem cell-derived miR-3614-5p exosomes suppress progression of colorectal cancer by targeting IL7Rα. |
|---|---|
| Authors: | Ye M; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.; Guangxi Cancer Molecular Medicine Engineering Research Center, Nanning, People's Republic of China.; Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Nanning, People's Republic of China., Bian Y; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China., Lin Y; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China., Li S; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China., Jiang L; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China., Wu J; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China., Xie Y; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.; Guangxi Cancer Molecular Medicine Engineering Research Center, Nanning, People's Republic of China.; Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Nanning, People's Republic of China., Ning S; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China.; Guangxi Cancer Molecular Medicine Engineering Research Center, Nanning, People's Republic of China.; Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Nanning, People's Republic of China., Liu Y; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China., Huang J; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China., Lei X; Department of Laboratory Medicine, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, People's Republic of China. lei.xinxing@szhospital.com., Zhang L; Department of Research, Guangxi Medical University Cancer Hospital, Nanning, People's Republic of China. zhanglitu@sr.gxmu.edu.cn.; Guangxi Cancer Molecular Medicine Engineering Research Center, Nanning, People's Republic of China. zhanglitu@sr.gxmu.edu.cn.; Guangxi Key Laboratory of Basic and Translational Research for Colorectal Cancer, Nanning, People's Republic of China. zhanglitu@sr.gxmu.edu.cn. |
| Source: | Journal of translational medicine [J Transl Med] 2026 May 21; Vol. 24 (1). Date of Electronic Publication: 2026 May 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
